Lena Willkomm is currently the Global Clinical Program Excellence Lead at Bayer Pharmaceuticals, a position they have held since 2024. Previously, they served as a Global Program Manager at Bayer Pharmaceuticals from 2020 to 2024 and as a Research Scientist. Lena completed a postdoctoral researcher role at Uniklinik Köln from 2014 to 2015 and held a research position at Deutsche Sporthochschule Köln in 2006-2007. They earned a Bachelor of Science in Molecular Medicine from Georg-August-Universität Göttingen, a Master of Science from the University of Glasgow, and a Dr. nat. med. in Molecular Medicine from Universität zu Köln.
This person is not in the org chart
This person is not in any teams
This person is not in any offices